Top Stories from Western Switzerland (January 2026)

From global commodity trading and space infrastructure to precision technologies, discover Western Switzerland’s top stories from January 2026.

Why Switzerland Is a Global Commodity Trading Superhub (A Conversation with Florence Schurch)

In this episode of Getting Serious with Woody Wade, Florence Schurch, Secretary General of SUISSENÉGOCE, explains how Switzerland became a global hub for commodity trading, how the sector operates across continents and why predictable regulation remains essential for both SMEs and multinational players. This episode is available on YouTube and Spotify.

TOFWERK acquired by Bruker to strengthening applied mass spectrometry capabilities

Bruker has completed the full acquisition of Bernese mass spectrometry specialist TOFWERK, reinforcing its applied small-molecule portfolio while preserving TOFWERK’s Swiss engineering base, R&D activities and brand identity in Thun.

Fribourg-based Revario reaches CHF 1 million turnover milestone

Cleantech sportswear start-up Revario has reached CHF 1 million in sales, marking a key milestone as the company prepares to expand beyond French-speaking Switzerland into German-speaking regions and neighbouring European markets.

SWISSto12 secures EUR 73 million ESA backing for HummingSat satellite platform

Renens-based aerospace company SWISSto12 secured EUR 73 million in funding from ESA member states to accelerate the development and industrialization of its compact geostationary HummingSat satellite platform for commercial and sovereign communications.

First stone laid for the JD7 building in Neuchâtel

The first stone of the JD7 building has been laid in Neuchâtel, marking a major step in the development of new laboratory and cleanroom infrastructure dedicated to microtechnology research and industrial innovation.

FluoSphera raises CHF 1.15 million to scale human-based preclinical drug testing

Geneva-based biotech start-up FluoSphera raised CHF 1.15 million to expand its human-relevant preclinical testing platform, supporting more predictive, non-animal drug development models and international growth.